Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Alteplase in Acute Ischemic Stroke
NCT05281549Phase 2Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2021
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tenecteplase in ischemic stroke, sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05281549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05281549.